Hepatocellular carcinoma (HCC) can be cured when diagnosed early but lack of awareness on safety and efficacy data for targeted therapies can be a barrier to patients receiving curative treatment. While multidisciplinary clinics have improved equity in treatment access, barriers still exist in provider education and patient management such as variable physician attendance and need for an intensive referral infrastructure. To help fill this gap, nurse navigators in community cancer settings are essential to patient outreach, coordinating with the multidisciplinary team as well as providing navigation services to patients and caretakers.
“HCC is a difficult disease to manage because of the multiple components of care required – no single provider can address all needs. A multidisciplinary approach puts patients at the center and results in better experience and outcomes.”
— Joel Wedd, MD, MPH, Director of the Liver Tumor Clinic, Emory Transplant Center, Emory Healthcare
Equitable Access to Quality Care for Unresectable Hepatocellular Carcinoma
In this video series, experts review the importance of importance of personalized treatment, factors for consideration when selecting treatment options, the impact of shared decision-decision making, real-world challenges, and ways that these challenges may be addressed.
Multidisciplinary Hepatocellular Carcinoma Effective Practice Guide
This report highlights effective practices in care coordination in action and provides valuable insights for cancer programs to consider. Findings from an environmental scan helped inform focus groups and interviews with three ACCC Member Programs exploring their effective practices in HCC care coordination.
Liver Cancer Heatmap
Access ACCC’s Liver Cancer Heatmap to better understand the current incidence, mortality rates, and health disparities that exist across the United States.
Hepatocellular Carcinoma Resource Hub
Explore this curated resource bank to learn more about screening and treatment guidelines, training opportunities, patient education, and clinical trials for HCC.
